110 related articles for article (PubMed ID: 8678435)
1. Adenovirus-mediated gene therapy for head and neck squamous cell carcinomas.
Goebel EA; Davidson BL; Zabner J; Graham SM; Kern JA
Ann Otol Rhinol Laryngol; 1996 Jul; 105(7):562-7. PubMed ID: 8678435
[TBL] [Abstract][Full Text] [Related]
2. Tumor reduction in vivo after adenoviral mediated gene transfer of the herpes simplex virus thymidine kinase gene and ganciclovir treatment in human head and neck squamous cell carcinoma.
Goebel EA; Davidson BL; Graham SM; Kern JA
Otolaryngol Head Neck Surg; 1998 Oct; 119(4):331-6. PubMed ID: 9781985
[TBL] [Abstract][Full Text] [Related]
3. Suicide gene therapy using adenovirus vector for human oral squamous carcinoma cell line in vitro.
Yamamoto N; Hayashi Y; Kagami H; Fukui T; Fukuhara H; Tohnai I; Ueda M; Mizuno M; Yoshida J
Nagoya J Med Sci; 2005 Jun; 67(3-4):83-91. PubMed ID: 17375474
[TBL] [Abstract][Full Text] [Related]
4. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line].
Huang H; Wang A
Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov; 36(6):457-60. PubMed ID: 11930726
[TBL] [Abstract][Full Text] [Related]
5. Cell death of human oral squamous cell carcinoma cell line induced by herpes simplex virus thymidine kinase gene and ganciclovir.
Nishikawa M; Hayashi Y; Yamamoto N; Fukui T; Fukuhara H; Mitsudo K; Tohnai I; Ueda M; Mizuno M; Yoshida J
Nagoya J Med Sci; 2003 Nov; 66(3-4):129-37. PubMed ID: 14727689
[TBL] [Abstract][Full Text] [Related]
6. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
Morris JC; Wildner O
Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
[TBL] [Abstract][Full Text] [Related]
7. Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vector.
Fukui T; Hayashi Y; Kagami H; Yamamoto N; Fukuhara H; Tohnai I; Ueda M; Mizuno M; Yoshida J
Oral Oncol; 2001 Apr; 37(3):211-5. PubMed ID: 11287273
[TBL] [Abstract][Full Text] [Related]
8. HDAC inhibitor valproic acid enhances tumor cell kill in adenovirus-HSVtk mediated suicide gene therapy in HNSCC xenograft mouse model.
Kothari V; Joshi G; Nama S; Somasundaram K; Mulherkar R
Int J Cancer; 2010 Feb; 126(3):733-42. PubMed ID: 19569045
[TBL] [Abstract][Full Text] [Related]
9. DNA-liposome complexes transduction of herpes simplex virus thymidine kinase renders human tongue cancer cell line sensitive to ganciclovir in vitro.
Wang JH; Situ ZQ; Wu JZ; Liu B
Chin J Dent Res; 2000 Dec; 3(4):44-8. PubMed ID: 11314087
[TBL] [Abstract][Full Text] [Related]
10. A tandemly repeated thyroglobulin core promoter has potential to enhance efficacy for tissue-specific gene therapy for thyroid carcinomas.
Takeda T; Yamazaki M; Minemura K; Imai Y; Inaba H; Suzuki S; Miyamoto T; Ichikawa K; Kakizawa T; Mori J; DeGroot LJ; Hashizume K
Cancer Gene Ther; 2002 Oct; 9(10):864-74. PubMed ID: 12224028
[TBL] [Abstract][Full Text] [Related]
11. Use of protamine to augment adenovirus-mediated cancer gene therapy.
Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
Kanai F; Shiratori Y; Yoshida Y; Wakimoto H; Hamada H; Kanegae Y; Saito I; Nakabayashi H; Tamaoki T; Tanaka T; Lan KH; Kato N; Shiina S; Omata M
Hepatology; 1996 Jun; 23(6):1359-68. PubMed ID: 8675152
[TBL] [Abstract][Full Text] [Related]
13. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration.
van der Eb MM; Cramer SJ; Vergouwe Y; Schagen FH; van Krieken JH; van der Eb AJ; Borel Rinkes IH; van de Velde CJ; Hoeben RC
Gene Ther; 1998 Apr; 5(4):451-8. PubMed ID: 9614568
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro.
Tanaka T; Kanai F; Okabe S; Yoshida Y; Wakimoto H; Hamada H; Shiratori Y; Lan K; Ishitobi M; Omata M
Cancer Res; 1996 Mar; 56(6):1341-5. PubMed ID: 8640823
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model.
O'Malley BW; Chen SH; Schwartz MR; Woo SL
Cancer Res; 1995 Mar; 55(5):1080-5. PubMed ID: 7866992
[TBL] [Abstract][Full Text] [Related]
16. Serum-resistant gene transfer to oral cancer cells by Metafectene and GeneJammer: application to HSV-tk/ganciclovir-mediated cytotoxicity.
Konopka K; Fallah B; Monzon-Duller J; Overlid N; Düzgünes N
Cell Mol Biol Lett; 2005; 10(3):455-70. PubMed ID: 16217556
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system.
Smythe WR; Hwang HC; Amin KM; Eck SL; Davidson BL; Wilson JM; Kaiser LR; Albelda SM
Cancer Res; 1994 Apr; 54(8):2055-9. PubMed ID: 8174104
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
Kaneko S; Hallenbeck P; Kotani T; Nakabayashi H; McGarrity G; Tamaoki T; Anderson WF; Chiang YL
Cancer Res; 1995 Nov; 55(22):5283-7. PubMed ID: 7585589
[TBL] [Abstract][Full Text] [Related]
19. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
20. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
